Application 065329

Type: ANDA
Sponsor: ACS DOBFAR

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	CEFTRIAXONE	CEFTRIAXONE SODIUM	INJECTABLE;INJECTION	EQ 500MG BASE/VIAL	No	No
002	CEFTRIAXONE	CEFTRIAXONE SODIUM	INJECTABLE;INJECTION	EQ 1GM BASE/VIAL	No	No
003	CEFTRIAXONE	CEFTRIAXONE SODIUM	INJECTABLE;INJECTION	EQ 2GM BASE/VIAL	No	No

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A065329-001	CEFTRIAXONE	CEFTRIAXONE SODIUM	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION	AP	2008-07-24
A065329-002	CEFTRIAXONE	CEFTRIAXONE SODIUM	EQ 1GM BASE/VIAL	INJECTABLE / INJECTION	AP	2008-07-24
A065329-003	CEFTRIAXONE	CEFTRIAXONE SODIUM	EQ 2GM BASE/VIAL	INJECTABLE / INJECTION	AP	2008-07-24

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A065329-001	AP
A065329-002	AP
A065329-003	AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A065329-001	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION	AP	2008-07-24	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065329-002	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INJECTION	AP	2008-07-24	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065329-003	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INJECTION	AP	2008-07-24	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065329-001	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION	AP	2008-07-24	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065329-002	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INJECTION	AP	2008-07-24	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065329-003	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INJECTION	AP	2008-07-24	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065329-001	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION	AP	2008-07-24	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065329-002	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INJECTION	AP	2008-07-24	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065329-003	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INJECTION	AP	2008-07-24	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065329-001	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION	AP	2008-07-24	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065329-002	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INJECTION	AP	2008-07-24	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065329-003	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INJECTION	AP	2008-07-24	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065329-001	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION	AP	2008-07-24	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065329-002	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INJECTION	AP	2008-07-24	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065329-003	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INJECTION	AP	2008-07-24	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065329-001	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION	AP	2008-07-24	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065329-002	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INJECTION	AP	2008-07-24	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065329-003	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INJECTION	AP	2008-07-24	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065329-001	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION	AP	2008-07-24	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065329-002	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INJECTION	AP	2008-07-24	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065329-003	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INJECTION	AP	2008-07-24	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065329-001	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION	AP	2008-07-24	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065329-002	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INJECTION	AP	2008-07-24	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065329-003	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INJECTION	AP	2008-07-24	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065329-001	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION	AP	2008-07-24	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065329-002	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INJECTION	AP	2008-07-24	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065329-003	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INJECTION	AP	2008-07-24	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065329-001	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION	AP	2008-07-24	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A065329-002	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INJECTION	AP	2008-07-24	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A065329-003	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INJECTION	AP	2008-07-24	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065329-001	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION	AP	2008-07-24	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065329-002	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INJECTION	AP	2008-07-24	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065329-003	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INJECTION	AP	2008-07-24	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065329-001	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION	AP	2008-07-24	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065329-002	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INJECTION	AP	2008-07-24	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065329-003	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INJECTION	AP	2008-07-24	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065329-001	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION	AP	2008-07-24	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065329-002	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INJECTION	AP	2008-07-24	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065329-003	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INJECTION	AP	2008-07-24	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A065329-001	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION	AP	2008-07-24	`8072bd15b7f6…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A065329-001	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065329-002	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065329-003	AP	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065329-001	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065329-002	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065329-003	AP	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065329-001	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065329-002	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065329-003	AP	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065329-001	AP	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065329-002	AP	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065329-003	AP	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065329-001	AP	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065329-002	AP	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065329-003	AP	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065329-001	AP	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065329-002	AP	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065329-003	AP	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065329-001	AP	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065329-002	AP	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065329-003	AP	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065329-001	AP	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065329-002	AP	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065329-003	AP	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065329-001	AP	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065329-002	AP	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065329-003	AP	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065329-001	AP	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A065329-002	AP	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A065329-003	AP	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065329-001	AP	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065329-002	AP	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065329-003	AP	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065329-001	AP	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065329-002	AP	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065329-003	AP	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065329-001	AP	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065329-002	AP	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065329-003	AP	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A065329-001	AP	1	`8072bd15b7f6…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 5 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Ceftriaxone	CEFTRIAXONE	WG Critical Care, LLC	7bed9b33-29e3-4f04-9766-43a21c7ad47a	2026-01-07	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065329 application number: ANDA065329 ndc (product): 44567-701 ndc (product): 44567-702
Ceftriaxone	CEFTRIAXONE	WG Critical Care, LLC	befd73ff-cb3b-4543-8a8e-bdb9b7fc1ff0	2025-04-07	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065329 application number: ANDA065329 ndc (product): 44567-701 ndc (product): 44567-700 ndc (product): 44567-702
ceftriaxone	CEFTRIAXONE	Sagent Pharmaceuticals	5cf93bc5-9e4c-4734-bc02-c7d0ac071022	2023-11-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065329 application number: ANDA065329 ndc (product): 25021-107 ndc (product): 25021-105 ndc (product): 25021-106
Ceftriaxone	CEFTRIAXONE	Fresenius Kabi USA, LLC	7ea1db43-40fa-417b-8911-ae98092070a0	2023-09-30	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065329 application number: ANDA065329 ndc (product): 63323-346 ndc (product): 63323-347
Ceftriaxone	CEFTRIAXONE	Proficient Rx LP	fcf401df-bcdc-4773-a63b-9741c0f74b3d	2022-11-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065329 application number: ANDA065329 ndc (product): 71205-593

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 66 matching rows.

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
25021-105	Ceftriaxone	Ceftriaxone	Sagent Pharmaceuticals	ANDA	Current
25021-105	ceftriaxone	ceftriaxone	Sagent Pharmaceuticals	ANDA	Current
25021-105	ceftriaxone	ceftriaxone	Sagent Pharmaceuticals	ANDA	Current
25021-105	Ceftriaxone	Ceftriaxone	Sagent Pharmaceuticals	ANDA	Current
25021-105	Ceftriaxone	Ceftriaxone	Sagent Pharmaceuticals	ANDA	Current
25021-105	Ceftriaxone	Ceftriaxone	Sagent Pharmaceuticals	ANDA	Current
25021-105	Ceftriaxone	Ceftriaxone	Sagent Pharmaceuticals	ANDA	Current
25021-105	ceftriaxone	ceftriaxone	Sagent Pharmaceuticals	ANDA	Current
25021-105	ceftriaxone	ceftriaxone	Sagent Pharmaceuticals	ANDA	Current
25021-105	ceftriaxone	ceftriaxone	Sagent Pharmaceuticals	ANDA	Current
25021-105	Ceftriaxone	Ceftriaxone	Sagent Pharmaceuticals	ANDA	Current
25021-105	ceftriaxone	ceftriaxone	Sagent Pharmaceuticals	ANDA	Current
25021-106	Ceftriaxone	Ceftriaxone	Sagent Pharmaceuticals	ANDA	Current
25021-106	ceftriaxone	ceftriaxone	Sagent Pharmaceuticals	ANDA	Current
25021-106	ceftriaxone	ceftriaxone	Sagent Pharmaceuticals	ANDA	Current
25021-106	Ceftriaxone	Ceftriaxone	Sagent Pharmaceuticals	ANDA	Current
25021-106	Ceftriaxone	Ceftriaxone	Sagent Pharmaceuticals	ANDA	Current
25021-106	Ceftriaxone	Ceftriaxone	Sagent Pharmaceuticals	ANDA	Current
25021-106	Ceftriaxone	Ceftriaxone	Sagent Pharmaceuticals	ANDA	Current
25021-106	Ceftriaxone	Ceftriaxone	Sagent Pharmaceuticals	ANDA	Current
25021-106	ceftriaxone	ceftriaxone	Sagent Pharmaceuticals	ANDA	Current
25021-106	ceftriaxone	ceftriaxone	Sagent Pharmaceuticals	ANDA	Current
25021-106	ceftriaxone	ceftriaxone	Sagent Pharmaceuticals	ANDA	Current
25021-106	Ceftriaxone	Ceftriaxone	Sagent Pharmaceuticals	ANDA	Current
25021-106	ceftriaxone	ceftriaxone	Sagent Pharmaceuticals	ANDA	Current
25021-107	Ceftriaxone	Ceftriaxone	Sagent Pharmaceuticals	ANDA	Current
25021-107	ceftriaxone	ceftriaxone	Sagent Pharmaceuticals	ANDA	Current
25021-107	ceftriaxone	ceftriaxone	Sagent Pharmaceuticals	ANDA	Current
25021-107	Ceftriaxone	Ceftriaxone	Sagent Pharmaceuticals	ANDA	Current
25021-107	Ceftriaxone	Ceftriaxone	Sagent Pharmaceuticals	ANDA	Current
25021-107	Ceftriaxone	Ceftriaxone	Sagent Pharmaceuticals	ANDA	Current
25021-107	Ceftriaxone	Ceftriaxone	Sagent Pharmaceuticals	ANDA	Current
25021-107	Ceftriaxone	Ceftriaxone	Sagent Pharmaceuticals	ANDA	Current
25021-107	ceftriaxone	ceftriaxone	Sagent Pharmaceuticals	ANDA	Current
25021-107	ceftriaxone	ceftriaxone	Sagent Pharmaceuticals	ANDA	Current
25021-107	ceftriaxone	ceftriaxone	Sagent Pharmaceuticals	ANDA	Current
25021-107	Ceftriaxone	Ceftriaxone	Sagent Pharmaceuticals	ANDA	Current
25021-107	ceftriaxone	ceftriaxone	Sagent Pharmaceuticals	ANDA	Current
44567-700	Ceftriaxone	Ceftriaxone	WG Critical Care, LLC	ANDA	Current
44567-700	Ceftriaxone	Ceftriaxone	WG Critical Care, LLC	ANDA	Current
44567-700	Ceftriaxone	Ceftriaxone	WG Critical Care, LLC	ANDA	Current
44567-700	Ceftriaxone	Ceftriaxone	WG Critical Care, LLC	ANDA	Current
44567-700	Ceftriaxone	Ceftriaxone	WG Critical Care, LLC	ANDA	Current
44567-700	Ceftriaxone	Ceftriaxone	WG Critical Care, LLC	ANDA	Current
44567-701	Ceftriaxone	Ceftriaxone	WG Critical Care, LLC	ANDA	Current
44567-701	Ceftriaxone	Ceftriaxone	WG Critical Care, LLC	ANDA	Current
44567-701	Ceftriaxone	Ceftriaxone	WG Critical Care, LLC	ANDA	Current
44567-701	Ceftriaxone	Ceftriaxone	WG Critical Care, LLC	ANDA	Current
44567-701	Ceftriaxone	Ceftriaxone	WG Critical Care, LLC	ANDA	Current
44567-701	Ceftriaxone	Ceftriaxone	WG Critical Care, LLC	ANDA	Current
44567-701	Ceftriaxone	Ceftriaxone	WG Critical Care, LLC	ANDA	Current
44567-702	Ceftriaxone	Ceftriaxone	WG Critical Care, LLC	ANDA	Current
44567-702	Ceftriaxone	Ceftriaxone	WG Critical Care, LLC	ANDA	Current
44567-702	Ceftriaxone	Ceftriaxone	WG Critical Care, LLC	ANDA	Current
44567-702	Ceftriaxone	Ceftriaxone	WG Critical Care, LLC	ANDA	Current
44567-702	Ceftriaxone	Ceftriaxone	WG Critical Care, LLC	ANDA	Current
44567-702	Ceftriaxone	Ceftriaxone	WG Critical Care, LLC	ANDA	Current
44567-702	Ceftriaxone	Ceftriaxone	WG Critical Care, LLC	ANDA	Current
63323-346	Ceftriaxone	Ceftriaxone	Fresenius Kabi USA, LLC	ANDA	Current
63323-346	Ceftriaxone	Ceftriaxone	Fresenius Kabi USA, LLC	ANDA	Current
63323-346	Ceftriaxone	Ceftriaxone	Fresenius Kabi USA, LLC	ANDA	Current
63323-347	Ceftriaxone	Ceftriaxone	Fresenius Kabi USA, LLC	ANDA	Current
63323-347	Ceftriaxone	Ceftriaxone	Fresenius Kabi USA, LLC	ANDA	Current
71205-593	Ceftriaxone	Ceftriaxone	Proficient Rx LP	ANDA	Current
71205-593	Ceftriaxone	Ceftriaxone	Proficient Rx LP	ANDA	Current
79144-101	Easy-Ceft	Ceftriaxone	American Health RX, LLC	ANDA	Current

Documents#

Document, Submission type, Date table
Document	Submission type	Date
44232	ORIG	2008-09-19